Search hospitals > Oregon > Portland
Veterans Affairs Medical Center - Portland
Claim this profilePortland, Oregon 97201
Global Leader in Lung Cancer
Global Leader in Prostate Cancer
Conducts research for Non-Small Cell Lung Cancer
Conducts research for Cancer
Conducts research for Lymphoma
163 reported clinical trials
9 medical researchers
Summary
Veterans Affairs Medical Center - Portland is a medical facility located in Portland, Oregon. This center is recognized for care of Lung Cancer, Prostate Cancer, Non-Small Cell Lung Cancer, Cancer, Lymphoma and other specialties. Veterans Affairs Medical Center - Portland is involved with conducting 163 clinical trials across 174 conditions. There are 9 research doctors associated with this hospital, such as Nima Nabavizadeh, MD, Alan R. Teo, MD MS, Rajan Kulkarni, and Matthew Koopmann, MD.Area of expertise
1Lung Cancer
Global LeaderStage II
Stage III
Stage I
2Prostate Cancer
Global LeaderStage IV
Top PIs
Nima Nabavizadeh, MDOHSU Knight Cancer Institute4 years of reported clinical research
Studies Cancer
Studies Liver Cancer
6 reported clinical trials
10 drugs studied
Alan R. Teo, MD MSVA Portland Health Care System, Portland, OR4 years of reported clinical research
Studies Loneliness
Studies Post-Traumatic Stress Disorder
4 reported clinical trials
6 drugs studied
Rajan KulkarniOregon Health and Science University4 years of reported clinical research
Studies Actinic Keratosis
Studies Skin Cancer
3 reported clinical trials
6 drugs studied
Matthew Koopmann, MDVA Portland Health Care System1 year of reported clinical research
Studies Aortic Aneurysm
Studies Abdominal Aortic Aneurysm
3 reported clinical trials
5 drugs studied
Clinical Trials running at Veterans Affairs Medical Center - Portland
Diffuse Large B-Cell Lymphoma
Lymphoma
Bladder Cancer
B-Cell Lymphoma
Traumatic Brain Injury
Supraventricular Tachycardia
Ventricular Tachycardia
Abdominal Aortic Aneurysm
Follicular Lymphoma
Alcoholism
Oral Azacitidine + R-miniCHOP
for Diffuse Large B-Cell Lymphoma
This phase II/III trial compares the side effects and activity of oral azacitidine in combination with the standard drug therapy (reduced dose rituximab-cyclophosphamide, doxorubicin, vincristine, and prednisone \[R-miniCHOP\]) versus R-miniCHOP alone in treating patients 75 years or older with newly diagnosed diffuse large B cell lymphoma. R-miniCHOP includes a monoclonal antibody (a type of protein), called rituximab, which attaches to the lymphoma cells and may help the immune system kill these cells. R-miniCHOP also includes prednisone which is an anti-inflammatory medication and a combination of 3 chemotherapy drugs, cyclophosphamide, doxorubicin, and vincristine. These 3 chemotherapy drugs, as well as oral azacitidine, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Combining oral azacitidine with R-miniCHOP may shrink the cancer or extend the time without disease symptoms coming back or extend patient's survival when compared to R-miniCHOP alone.
Recruiting1 award Phase 2 & 314 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Veterans Affairs Medical Center - Portland?
Veterans Affairs Medical Center - Portland is a medical facility located in Portland, Oregon. This center is recognized for care of Lung Cancer, Prostate Cancer, Non-Small Cell Lung Cancer, Cancer, Lymphoma and other specialties. Veterans Affairs Medical Center - Portland is involved with conducting 163 clinical trials across 174 conditions. There are 9 research doctors associated with this hospital, such as Nima Nabavizadeh, MD, Alan R. Teo, MD MS, Rajan Kulkarni, and Matthew Koopmann, MD.